Avience Biomedicals (NSE:AVIENCE) EV-to-EBITDA: (As of Aug. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
18 GF Score
Price ₹250.90
! 3 Warning Signs
View Full Analysis

What is Avience Biomedicals EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Avience Biomedicals's enterprise value is ₹1,627.5 Mil. Avience Biomedicals does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Mar. 2025. Therefore, GuruFocus does not calculate Avience Biomedicals's EV-to-EBITDA at this moment.

The historical rank and industry rank for Avience Biomedicals's EV-to-EBITDA or its related term are showing as below:

NSE:AVIENCE' s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.58   Med: 13.27   Max: 20.34
Current: 13.52

During the past 3 years, the highest EV-to-EBITDA of Avience Biomedicals was 20.34. The lowest was 11.58. And the median was 13.27.

NSE:AVIENCE's EV-to-EBITDA is ranked better than
54.28% of 514 companies
in the Medical Devices & Instruments industry
Industry Median: 14.825 vs NSE:AVIENCE: 13.52

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-08-13), Avience Biomedicals's stock price is ₹250.90. Avience Biomedicals does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025. Therefore, GuruFocus does not calculate Avience Biomedicals's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

Avience Biomedicals  (NSE:AVIENCE) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Avience Biomedicals's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=250.90/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Avience Biomedicals EV-to-EBITDA Related Terms

Avience Biomedicals EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals EV-to-EBITDA Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
EV-to-EBITDA
0.00 0.00 0.00

Avience Biomedicals Semi-Annual Data
Mar23 Mar24 Mar25
EV-to-EBITDA 0.00 0.00 0.00

NSE:AVIENCE vs ABT, SYK, MDT: EV-to-EBITDA Comparison

For the Medical Devices subindustry, Avience Biomedicals's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avience Biomedicals EV-to-EBITDA vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avience Biomedicals's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Avience Biomedicals's EV-to-EBITDA falls into.


NSE:AVIENCE
18GF Score
Avience Biomedicals Ltd NSE:AVIENCE
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals EV-to-EBITDA Calculation

Avience Biomedicals's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1627.548/
=

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
18GF Score

Get the complete analysis for NSE:AVIENCE

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹250.90
Price